The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma

por Bill, Kate Lynn J., Garnett, Jeannine, Ma, Xiaoyan, May, Caitlin, Bolshakov, Svetlana, Lazar, Alexander J., Lev, Dina, Pollock, Raphael E.
Publicado 2015

HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)

por Lopez, Gonzalo, Bill, Kate Lynn J., Bid, Hemant Kumar, Braggio, Danielle, Constantino, Dylan, Prudner, Bethany, Zewdu, Abeba, Batte, Kara, Lev, Dina, Pollock, Raphael E.
Publicado 2015

MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models

por Patt, Andrew, Demoret, Bryce, Stets, Colin, Bill, Kate-Lynn, Smith, Philip, Vijay, Anitha, Patterson, Andrew, Hays, John, Hoang, Mindy, Chen, James L., Mathé, Ewy A.
Publicado 2020

miR-133a function in the pathogenesis of dedifferentiated liposarcoma

por Yu, Peter Y., Lopez, Gonzalo, Braggio, Danielle, Koller, David, Bill, Kate Lynn J., Prudner, Bethany C., Zewdu, Abbie, Chen, James L., Iwenofu, O. Hans, Lev, Dina, Strohecker, Anne M., Fenger, Joelle M., Pollock, Raphael E., Guttridge, Denis C.
Publicado 2018